Neurology
RSSArticles
-
Intensive Lipid Lowering in ACS Patients Undergoing PCI
Intensive lipid lowering with statin therapy (atorvastatin 80 mg) in patients presenting with acute coronary syndromes (ACS) resulted in improved outcomes compared to treatment with moderate lipid lowering (pravastatin 40 mg) in the PROVE-IT TIMI-22 study (Cannon et al. N Engl J Med. 2004;350:1495-1504), which included patients treated conservatively, as well as those treated with percutaneous coronary intervention (PCI). -
Emergency Medicine Reports - Full February 1, 2010 Issue in Streaming Audio/Downloadable MP3 Format
-
Complications of Prosthetic Heart Valves in the Emergency Department
More than 100,000 prosthetic heart valves are implanted each year in North America, and another 300,000 are done annually worldwide. -
Emergency Medicine Reports - Full February 1, 2010 Issue in PDF
-
Medical Advances in the Evaluation and Treatment of Heart Failure
Congestive heart failure (CHF) is the most common DRG for Medicare patients in U.S. hospitals and is therefore the target of considerable regulatory attention due to its financial impact on the federal budget. -
Pharmacology Watch
Results from a Phase 3 study of dabigatran, intensive lipid-lowering in CVD, H1N1 vaccine dosing and efficacy, and FDA Actions -
Clinical Briefs in Primary Care Supplement
-
Primary Care Reports - Full February 2010 Issue in PDF
-
Ocular Myasthenia in Seniors: A Case for Treatment
Immunomodulatory therapy reduces the rate of conversion to generalized myasthenia gravis in seniors with pure ocular myasthenia. -
Neuropathy in Liver Failure
Neuropathy occurs with a high frequency in patients with end-stage liver disease, but rarely causes disability.